financetom
Business
financetom
/
Business
/
Assured Guaranty Insider Sold Shares Worth $2,480,286, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Assured Guaranty Insider Sold Shares Worth $2,480,286, According to a Recent SEC Filing
Sep 6, 2024 2:02 PM

04:32 PM EDT, 09/06/2024 (MT Newswires) -- Dominic Frederico, Director, President, CEO, Deputy Chairman, on September 04, 2024, sold 31,000 shares in Assured Guaranty ( AGO ) for $2,480,286. Following the Form 4 filing with the SEC, Frederico has control over a total of 1,734,719 shares of the company, with 1,380,119 shares held directly and 354,600 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1273813/000121390024076545/xslF345X05/marketforms-66934.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nu Skin Enterprises' Unit Sells Mavely Platform for $250 Million; Shares Rise
Nu Skin Enterprises' Unit Sells Mavely Platform for $250 Million; Shares Rise
Jan 3, 2025
07:18 AM EST, 01/03/2025 (MT Newswires) -- Nu Skin Enterprises ( NUS ) said Friday that its Rhyz unit has sold its Mavely marketing technology platform to Later, a portfolio company of Summit Partners, for $250 million. The purchase price was in cash and a minority equity stake in the combined Later/Mavely business, the company said. Shares of Nu Skin...
Eton Pharmaceuticals Acquires Galzin to Expand Rare Disease Treatment Offerings
Eton Pharmaceuticals Acquires Galzin to Expand Rare Disease Treatment Offerings
Jan 3, 2025
07:19 AM EST, 01/03/2025 (MT Newswires) -- Eton Pharmaceuticals ( ETON ) said Friday that it acquired Galzin, an FDA-approved treatment for Wilson Disease. The company plans to begin US commercialization in Q1 2025 and offer personalized support through its Eton Cares program, including a $0 co-pay for eligible patients. Additionally, Eton said it acquired European rights to the product,...
GSK Says China Approval Secured for Nucala to Treat Adults With Chronic Rhinosinusitis With Nasal Polyps
GSK Says China Approval Secured for Nucala to Treat Adults With Chronic Rhinosinusitis With Nasal Polyps
Jan 3, 2025
07:17 AM EST, 01/03/2025 (MT Newswires) -- GSK (GSK) said Friday that the China National Medical Products Administration has approved Nucala, or mepolizumab, as an add-on therapy with intranasal corticosteroids to treat adult patients with inadequately controlled chronic rhinosinusitis with nasal polyps. The company said the approval was based on the results of a phase 3 trial of mepolizumab in...
Stellantis Italy output falls 37% in 2024, car production hits 68-year low 
Stellantis Italy output falls 37% in 2024, car production hits 68-year low 
Jan 3, 2025
MILAN (Reuters) -Vehicle production by car maker Stellantis in Italy fell by 37% last year, hit in particular by a steep plunge in car manufacturing, union figures showed on Friday. To address overcapacity in Italy, the group has relied heavily on state-funded temporary layoff schemes. Stellantis in December presented a plan to boost production, but an increase is only expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved